The global Cannabidiol Market size was valued at USD 6,997.9 million in 2023 and is projected to reach USD 20,691.5 million by 2031, growing at a CAGR of 14.53% from 2024 to 2031. The market is experiencing substantial growth due to increasing consumer awareness regarding the therapeutic benefits of cannabidiol (CBD), expanding legalization of cannabis-derived products, and rising demand for natural wellness solutions. Growing applications of CBD across pharmaceuticals, food and beverages, cosmetics, dietary supplements, and healthcare products are further driving market expansion. Moreover, continuous research and development activities, favorable regulatory developments in several countries, and increasing investments by key market participants are expected to create lucrative opportunities throughout the forecast period.
Get the Full Detailed Insights Report: https://www.kingsresearch.com/cannabidiol-market-628
Cannabidiol Market Overview
The cannabidiol market has emerged as one of the fastest-growing segments within the global cannabis industry. Cannabidiol, commonly known as CBD, is a naturally occurring compound extracted primarily from hemp and marijuana plants. Unlike tetrahydrocannabinol (THC), CBD is non-psychoactive, making it highly attractive for medical, therapeutic, and wellness applications.
CBD has gained widespread acceptance owing to its potential therapeutic properties, including pain relief, anxiety reduction, anti-inflammatory effects, seizure management, and sleep improvement. Consumers are increasingly seeking plant-based alternatives for health management, fueling demand for CBD-infused products across various industries.
The pharmaceutical sector continues to be a major growth contributor as pharmaceutical companies invest in cannabinoid-based drug development for neurological disorders, chronic pain, epilepsy, and mental health conditions. Additionally, CBD has become increasingly popular in personal care products, including skincare creams, lotions, shampoos, serums, and cosmetics, due to its antioxidant and anti-inflammatory properties.
The growing trend toward preventive healthcare, coupled with increasing disposable income and expanding retail availability of CBD products, is further supporting market growth. Online distribution channels have also accelerated product accessibility, enabling manufacturers to reach a broader customer base globally.
Key Highlights
- Market Size (2023): USD 6,997.9 Million
- Projected Market Size (2031): USD 20,691.5 Million
- Forecast CAGR (2024–2031): 14.53%
- Increasing legalization of hemp-derived CBD products
- Growing demand for plant-based wellness and healthcare products
- Rising pharmaceutical research on cannabinoid therapies
- Expanding CBD applications in cosmetics, beverages, and dietary supplements
- Increasing investments and product innovation by major manufacturers
Growth Drivers
Expanding Legalization of Cannabis-Derived Products
One of the primary drivers of the cannabidiol market is the gradual legalization of cannabis and hemp-derived CBD products across several countries. Governments are introducing supportive regulatory frameworks that permit the cultivation, manufacturing, and commercialization of cannabidiol products under controlled conditions.
This evolving regulatory landscape has encouraged investments from pharmaceutical companies, consumer goods manufacturers, and wellness brands, significantly expanding market opportunities.
Growing Consumer Preference for Natural Wellness Products
Consumers worldwide are increasingly shifting toward natural and plant-based health solutions. CBD products have gained popularity due to their perceived benefits in managing anxiety, stress, chronic pain, inflammation, and sleep disorders.
The rising awareness of holistic healthcare and preventive wellness continues to strengthen demand for cannabidiol-based products across multiple end-use industries.
Increasing Pharmaceutical Research
The pharmaceutical industry is investing heavily in cannabinoid research to develop innovative therapies for neurological disorders, epilepsy, multiple sclerosis, chronic pain, and mental health conditions.
Clinical studies exploring the medical applications of cannabidiol are expected to create new growth opportunities for pharmaceutical-grade CBD products over the forecast period.
Rising Demand in Personal Care and Cosmetics
CBD has become a valuable ingredient in skincare and beauty products due to its anti-inflammatory, antioxidant, and moisturizing properties. Manufacturers are increasingly launching CBD-infused creams, facial serums, lotions, shampoos, and cosmetic products to meet rising consumer demand for premium natural beauty solutions.
Latest Market Trends
Rapid Growth of CBD-Infused Functional Foods and Beverages
The food and beverage industry is witnessing increasing adoption of cannabidiol as manufacturers introduce CBD-infused beverages, chocolates, gummies, snacks, coffee, and wellness drinks. Consumers are seeking functional food products that provide relaxation and wellness benefits.
Expansion of E-commerce Distribution Channels
Online retail has become a major sales channel for cannabidiol products. E-commerce platforms enable manufacturers to offer a wider product portfolio while providing consumers with convenient access to CBD oils, capsules, cosmetics, and supplements.
Increasing Product Innovation
Manufacturers are continuously introducing innovative product formats, including water-soluble CBD, nano-emulsified formulations, soft gels, transdermal patches, and CBD-infused personal care products to improve consumer experience and product effectiveness.
Growing Investments in Research and Development
Companies are investing significantly in research activities to improve extraction technologies, enhance product purity, and develop pharmaceutical-grade cannabidiol formulations. These innovations are expected to support long-term market expansion.
Market Segmentation Analysis
By Type
Hemp
The hemp segment accounts for the largest share of the global cannabidiol market due to favorable regulatory frameworks in several countries and the low THC content of hemp-derived CBD. Hemp-based cannabidiol products are extensively used in dietary supplements, cosmetics, wellness products, and food applications.
The increasing legalization of industrial hemp cultivation and growing consumer preference for non-psychoactive products continue to support this segment.
Marijuana
Marijuana-derived cannabidiol products are primarily utilized for pharmaceutical and medical applications where broader cannabinoid profiles may be required. Growing medical cannabis legalization across various countries is expected to support steady growth in this segment.
Research into therapeutic applications of marijuana-derived CBD continues to create new opportunities within the healthcare sector.
By End-Use
Pharmaceutical
The pharmaceutical segment represents one of the fastest-growing application areas for cannabidiol. CBD is increasingly utilized in the treatment of epilepsy, chronic pain, anxiety disorders, neurological conditions, and inflammation-related diseases.
Pharmaceutical companies are expanding research programs to develop cannabinoid-based prescription medications, driving demand for pharmaceutical-grade cannabidiol.
Food and Beverage
CBD-infused food and beverage products have gained considerable popularity among health-conscious consumers. Functional beverages, nutritional snacks, confectionery products, and wellness drinks are increasingly incorporating cannabidiol as a functional ingredient.
Manufacturers continue expanding product offerings to meet evolving consumer preferences.
Personal Care & Cosmetic
The personal care and cosmetic industry is witnessing rapid adoption of cannabidiol due to its antioxidant, anti-aging, moisturizing, and anti-inflammatory properties. CBD-infused skincare products, facial oils, creams, lip balms, shampoos, and body lotions are becoming increasingly popular among consumers seeking natural beauty products.
Dietary Supplements
Dietary supplements constitute a major application segment, with cannabidiol available in capsules, soft gels, tinctures, gummies, and powders. Consumers increasingly use CBD supplements to support relaxation, sleep quality, immune health, and general wellness.
Growing awareness regarding preventive healthcare is expected to further drive this segment.
Others
Other applications include veterinary healthcare, sports nutrition, pet wellness, and industrial formulations. Continuous product innovation is expanding cannabidiol applications beyond traditional healthcare markets.
Regional Analysis
North America
North America dominates the global cannabidiol market due to widespread legalization of hemp-derived CBD products, advanced healthcare infrastructure, strong consumer awareness, and significant investments in research and development. The United States remains the largest regional market owing to favorable regulatory developments and increasing product availability.
The presence of major CBD manufacturers and well-established distribution networks further supports regional growth.
Europe
Europe represents a significant market driven by increasing consumer acceptance, expanding pharmaceutical research, and favorable regulations governing industrial hemp cultivation. Countries including Germany, the United Kingdom, Switzerland, and the Netherlands are witnessing increasing demand for CBD-based healthcare and wellness products.
Growing investments in pharmaceutical cannabinoid research continue supporting regional market expansion.
Asia-Pacific
Asia-Pacific is anticipated to register the fastest growth during the forecast period. Rising healthcare awareness, increasing disposable income, expanding pharmaceutical manufacturing, and evolving regulatory frameworks are contributing to market development.
Countries such as Australia, Japan, South Korea, Thailand, and India are gradually expanding cannabidiol research and commercial activities.
Latin America
Latin America is experiencing increasing market growth due to expanding medical cannabis legalization, improving healthcare infrastructure, and rising investments in cannabinoid research. Countries such as Brazil, Colombia, and Uruguay are emerging as attractive markets for cannabidiol products.
Middle East & Africa
The Middle East & Africa market remains at an early stage but is expected to witness gradual growth as regulatory policies evolve and awareness regarding the medical benefits of cannabidiol increases. Growing pharmaceutical research and healthcare investments are likely to support future market expansion.
Competitive Landscape
The global cannabidiol market is highly competitive, with established pharmaceutical companies, cannabis producers, wellness brands, and biotechnology firms focusing on product innovation, strategic partnerships, acquisitions, and geographical expansion. Market participants are investing heavily in research and development to improve extraction technologies, enhance product quality, and develop new CBD formulations for pharmaceutical and consumer applications.
Companies are expanding manufacturing capacities, strengthening supply chain capabilities, and launching diversified product portfolios to address increasing consumer demand across healthcare, cosmetics, dietary supplements, and food industries. Strategic collaborations with healthcare providers, retailers, and research organizations are further enabling companies to strengthen their market presence and enhance product accessibility.
Growing investments in clinical research, quality assurance, and regulatory compliance are expected to remain key competitive strategies throughout the forecast period.
Future Outlook
The future of the global cannabidiol market appears highly promising, supported by increasing legalization, expanding medical research, and growing consumer demand for natural wellness products. The pharmaceutical sector is expected to remain a major growth engine as ongoing clinical trials continue to validate the therapeutic potential of cannabidiol for various medical conditions.
Product innovation will play a critical role in shaping future market growth, with manufacturers focusing on improved bioavailability, advanced delivery systems, and premium wellness formulations. The expansion of CBD-infused functional foods, beverages, cosmetics, and dietary supplements is expected to create additional revenue opportunities.
North America is likely to maintain its market leadership, while Asia-Pacific is projected to emerge as the fastest-growing regional market due to increasing healthcare investments and evolving regulatory support. Europe will continue witnessing stable growth driven by pharmaceutical applications and consumer acceptance of hemp-derived products.
Overall, the cannabidiol market is expected to experience strong and sustained growth throughout the forecast period, supported by favorable regulations, technological advancements, and increasing adoption across diverse end-use industries.
About Kings Research
Kings Research is a leading market research and consulting firm that provides comprehensive market intelligence, industry analysis, and strategic business insights across a wide range of industries. Through in-depth market assessments, emerging trend analysis, competitive intelligence, and data-driven forecasting, Kings Research enables organizations to make informed business decisions, identify growth opportunities, and navigate evolving market dynamics with confidence.
